Product correctly added to cart.

discount label
Fmoc-S-benzyl-D-penicillamine
View 3D

Biosynth logo

Fmoc-S-benzyl-D-penicillamine

CAS: 139551-73-8

Ref. 3D-FF47876

1gTo inquire
2gTo inquire
5gTo inquire
250mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Thursday 9 Jan 2025

Product Information

Name:
Fmoc-S-benzyl-D-penicillamine
Synonyms:
  • Fmoc-D-Pen(Bzl)-OHFmoc-S-benzyl-b,b-dimethyl-D-Cys-OH
Description:

Fmoc-S-benzyl-D-penicillamine is a potent locomotor activity activator. It binds to specific receptors in the central nervous system and stimulates the release of neuropeptides, which are responsible for locomotor activity. Fmoc-S-benzyl-D-penicillamine is also a potent stimulatory compound that functions by activating receptor systems. This ligand has been synthesized and its activity confirmed in animals. It has high potency, with its effects being due to its cyclic and aliphatic structure. Fmoc-S-benzyl-D-penicillamine is a potent ligand that has been shown to have high potency in animal studies, with its effects being due to its cyclic and aliphatic structure.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
461.57 g/mol
Formula:
C27H27NO4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FF47876 Fmoc-S-benzyl-D-penicillamine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".